|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-5-31
|
|
pubmed:abstractText |
Hyperglucagonemia has been described to be associated with insulin resistance in patients with liver cirrhosis. Portosystemic shunts may be involved in the etiology of hyperglucagonemia. To test this hypothesis we investigated fasting peripheral plasma glucagon levels before and after portal decompression by transjugular intrahepatic portosystemic shunting (TIPS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0947-7349
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
113
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
268-74
|
|
pubmed:meshHeading |
pubmed-meshheading:15926112-Adult,
pubmed-meshheading:15926112-Aged,
pubmed-meshheading:15926112-Blood Glucose,
pubmed-meshheading:15926112-C-Peptide,
pubmed-meshheading:15926112-Diabetes Complications,
pubmed-meshheading:15926112-Female,
pubmed-meshheading:15926112-Glucagon,
pubmed-meshheading:15926112-Hemoglobin A, Glycosylated,
pubmed-meshheading:15926112-Humans,
pubmed-meshheading:15926112-Hypertension, Portal,
pubmed-meshheading:15926112-Liver Cirrhosis,
pubmed-meshheading:15926112-Male,
pubmed-meshheading:15926112-Middle Aged,
pubmed-meshheading:15926112-Portasystemic Shunt, Transjugular Intrahepatic
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts (TIPS).
|
|
pubmed:affiliation |
Department of Gastroenterology and Endocrinology, Georg-August-Universität Göttingen, Göttingen, Germany. draddat@gwdg.de
|
|
pubmed:publicationType |
Journal Article
|
